These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 14669288

  • 1. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
    Nagaoka S, Yatsuhashi H, Hamada H, Yano K, Matsumoto T, Daikoku M, Arisawa K, Ishibashi H, Koga M, Sata M, Yano M.
    Cancer; 2003 Dec 15; 98(12):2671-7. PubMed ID: 14669288
    [Abstract] [Full Text] [Related]

  • 2. Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC).
    Murakami N, Tamano M, Yoneda M, Sugaya H, Hiraishi H.
    Hepatogastroenterology; 2008 Dec 15; 55(81):197-201. PubMed ID: 18507106
    [Abstract] [Full Text] [Related]

  • 3. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
    Uehara S, Gotoh K, Handa H, Tomita H, Senshuu M.
    J Gastroenterol Hepatol; 2005 Oct 15; 20(10):1545-52. PubMed ID: 16174072
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M.
    Cancer; 2000 Feb 01; 88(3):544-9. PubMed ID: 10649245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K, Magario N, Yokoo T, Naraki T.
    Cancer; 1999 Feb 15; 85(4):812-8. PubMed ID: 10091758
    [Abstract] [Full Text] [Related]

  • 7. Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma.
    Sugimoto H, Takeda S, Inoue S, Kaneko T, Watanabe K, Nakao A.
    Liver Int; 2003 Feb 15; 23(1):38-44. PubMed ID: 12640726
    [Abstract] [Full Text] [Related]

  • 8. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H.
    Cancer; 2009 Feb 01; 115(3):571-80. PubMed ID: 19117347
    [Abstract] [Full Text] [Related]

  • 9. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 01; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
    Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.
    Am J Gastroenterol; 2006 Sep 01; 101(9):2038-43. PubMed ID: 16848811
    [Abstract] [Full Text] [Related]

  • 11. A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma.
    Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, Enokimura N, Yamamoto N, Okano H, Sugimoto K, Murata K, Yamakado K, Takeda K, Nakano T.
    Int J Oncol; 2003 Oct 01; 23(4):1115-20. PubMed ID: 12963993
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Oct 01; 50(54):2072-8. PubMed ID: 14696467
    [Abstract] [Full Text] [Related]

  • 14. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M.
    Liver Int; 2007 Oct 01; 27(8):1091-7. PubMed ID: 17845537
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
    Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S.
    Br J Surg; 1999 Aug 01; 86(8):1032-8. PubMed ID: 10460639
    [Abstract] [Full Text] [Related]

  • 17. Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma.
    Takeji S, Hirooka M, Koizumi Y, Tokumoto Y, Abe M, Ikeda Y, Nadano S, Hiasa Y, Onji M.
    J Gastroenterol Hepatol; 2013 Apr 01; 28(4):671-7. PubMed ID: 23215762
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
    Toyoda H, Kumada T, Kaneoka Y, Osaki Y, Kimura T, Arimoto A, Oka H, Yamazaki O, Manabe T, Urano F, Chung H, Kudo M, Matsunaga T.
    J Hepatol; 2008 Aug 01; 49(2):223-32. PubMed ID: 18571271
    [Abstract] [Full Text] [Related]

  • 19. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods.
    Nomura F, Ishijima M, Horikoshi A, Nakai T, Ohnishi K.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1380-3. PubMed ID: 8677999
    [Abstract] [Full Text] [Related]

  • 20. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 01; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.